Terrie Curran
2023
In 2023, Terrie Curran earned a total compensation of $3.4M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $518,152 |
---|---|
Option Awards | $830,538 |
Salary | $687,500 |
Stock Awards | $1,357,957 |
Other | $16,875 |
Total | $3,411,022 |
Curran received $1.4M in stock awards, accounting for 40% of the total pay in 2023.
Curran also received $518.2K in non-equity incentive plan, $830.5K in option awards, $687.5K in salary and $16.9K in other compensation.
Rankings
In 2023, Terrie Curran's compensation ranked 244th out of 2,983 executives tracked by ExecPay. In other words, Curran earned more than 91.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 244 | 92nd |
Manufacturing | 130 | 92nd |
Chemicals And Allied Products | 91 | 90th |
Drugs | 89 | 90th |
Pharmaceutical Preparations | 56 | 91st |
Curran's colleagues
We found two more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2023.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020